TP53 and triple-negative breast carcinoma: Besides, targeted genes that transcriptionally repressed by p53 were frequently overexpressed in tumors [31], and Zhang et al. found p53 increased accompanied with CDC20 decreased after drug treatment in triple-negative breast cancer [32], we hypothesized that a negative regulatory relationship between p53 and CDC20 also existed in MCL.